An optogenetics-compatible red fluorescent calcium indicator with negligible blue light photoactivation

The authors engineered ScaRCaMP, a novel red fluorescent calcium indicator based on mScarlet variants that exhibits negligible blue-light photoactivation and high photostability, making it uniquely suitable for optogenetics-compatible imaging in live cells and in vivo.

The Gist

The Big Problem: The "Flashlight" Dilemma

Imagine you are trying to watch a movie in a dark room (your brain cell). You want to see the actors (neurons) moving around, so you use a special camera (a calcium indicator) that glows when the actors are active.

However, to make the actors move, you need to use a remote control that shoots a beam of blue light (this is optogenetics).

Here is the catch: The camera you are using is made of a material that is sensitive to blue light. When you turn on the remote to make the actors move, the camera itself gets blinded by the blue light and starts flashing wildly. You can't tell if the camera is flashing because the actors moved, or just because you turned on the remote.

For years, scientists had to choose: either use the blue remote and get a blurry, flashing camera, or turn off the remote and just watch the actors quietly. They couldn't do both at the same time.

The Solution: A "Blue-Proof" Camera

The researchers in this paper wanted to build a new camera that is immune to blue light. They wanted a camera that only glows when the neurons are active, and stays perfectly calm even when blasted with intense blue light.

They decided to build this new camera using a specific type of red glowing protein called mScarlet. Think of mScarlet as a very tough, high-quality red paint that doesn't react to blue light.

The Process: Mixing and Matching

1. The Prototype (ScaRCaMP-1.0):
   The team took the tough red paint (mScarlet) and mixed it with a "calcium sensor" (a part that changes shape when it touches calcium). They created a prototype called ScaRCaMP-1.0.

   • The Result: It worked! When they blasted it with blue light (even very strong blue light), it didn't flash or glitch. It was "blue-proof."
   • The Trade-off: The camera was a bit dim. When the neurons fired, the red glow got slightly darker (a 13% drop) instead of getting brighter. It was like a dimmer switch that turned the lights down a little bit, rather than a spotlight that turned them up.

2. The Upgrade (ScaRCaMP-2.0):
   The team wanted to make the signal stronger without losing the blue-proof feature. They looked at the "blueprint" of the camera using a super-smart AI (AlphaFold3) to see how the parts fit together.

   • They found two tiny "latches" (specific amino acids) on the surface of the red paint that seemed to control how the camera reacted to calcium.
   • They tweaked one of these latches (changing a specific part called K132).
   • The Result: This created ScaRCaMP-2.0. It was still blue-proof, but now the signal was much stronger (a 22% drop in brightness). It was like upgrading from a dim nightlight to a bright porch light, while keeping the blue-proof shield intact.

Why This Matters

Before this paper, scientists trying to study the brain had to be very careful. If they used blue light to control neurons, they had to use green cameras, which often got confused by the blue light. If they used red cameras, the blue light would make the red cameras glitch out.

ScaRCaMP is the "Best of Both Worlds" tool:

• It's Red: So it doesn't clash with green tools.
• It's Blue-Proof: So scientists can blast the brain with blue light to control neurons, and the camera will just keep recording the activity perfectly without getting confused.

The Real-World Test

The team didn't just test this in a petri dish; they tested it in live mice.

• They injected the new camera into the brains of mice.
• They let the mice run on a wheel while shining blue light into their brains to stimulate neurons.
• The Outcome: The camera recorded the brain activity clearly, even while the blue light was firing. It proved that you can finally "write" to the brain (with blue light) and "read" from the brain (with the red camera) at the exact same time without the two interfering with each other.

Summary Analogy

Think of the brain as a busy city.

• Neurons are the cars.
• Calcium Indicators are the streetlights that turn on when cars pass.
• Optogenetics (Blue Light) is a traffic controller waving a blue baton to make cars move.

The Old Problem: The streetlights were made of glass that shattered when the traffic controller waved the blue baton. You couldn't see the cars because the streetlights were broken.

The New Solution (ScaRCaMP): The scientists built streetlights out of bulletproof red plastic. Now, the traffic controller can wave the blue baton as hard as he wants, and the streetlights stay intact, clearly showing exactly where the cars are going.

This discovery opens the door for much more complex experiments, allowing scientists to control and observe the brain simultaneously with unprecedented clarity.

Technical Summary

1. Problem Statement

Calcium imaging using Genetically Encoded Calcium Indicators (GECIs) is essential for monitoring neural activity. However, combining red GECIs with optogenetic tools (which typically use blue light for activation) presents significant challenges:

• Spectral Crosstalk: Green GECIs absorb blue light, interfering with optogenetic activation.
• Blue-Light-Induced Artifacts: Existing red GECIs (e.g., jRGECO1a, jRCaMP1a/b) often exhibit photoswitching or photoactivation when exposed to blue light. This phenomenon, inherent to the fluorescent proteins (FPs) they are built upon (such as mApple and mRuby), causes fluorescence changes that mimic calcium transients.
• Limitation: These artifacts scale with illumination power, making it difficult to use high-power blue light (required for deep-tissue optogenetics) without corrupting calcium imaging data.

2. Methodology

The authors employed a rational design and high-throughput screening approach to engineer a new class of red GECIs based on photostable fluorescent proteins.

• Fluorophore Selection: Instead of mApple or mRuby, the team selected the mScarlet lineage (specifically mScarlet3, mScarlet-I3, and mScarlet-I) and mCherry-XL, known for their resistance to blue-light-induced photoswitching.
• Design Topologies: They tested two classic GECI architectures:
  1. Circularly Permuted FP (cpFP): Similar to GCaMP/RCaMP designs.
  2. Split-FP: Similar to NEMOf designs.
• Library Screening:
  • Initial constructs were tested in HEK293T cells.
  • Library 1 & 2: Focused on cpFP designs using cpmScarlet3 and cpmScarlet-I3. They generated libraries by varying flexible peptide linkers connecting the FP to the Calmodulin (CaM) and RS20 peptide domains. They also sampled specific residues (F1 and F4 positions) adjacent to the linker.
  • Screening Protocol: Cells were imaged under three conditions: baseline, high calcium (ionomycin), and low calcium (EGTA). Responses were normalized against a co-expressed green fluorescent protein (mTurquoise2) to correct for motion and expression levels.
• Characterization:
  • In Vitro: Purified protein characterization (spectra, quantum yield, extinction coefficient).
  • Cellular: Calcium titration curves in permeabilized cells to determine affinity ($IC_{50}$) and cooperativity (Hill coefficient).
  • Photostability: Tested against 1-photon and 2-photon illumination.
  • Optogenetic Compatibility: Co-expressed with the blue-light-sensitive channel CoChR. Cells were stimulated with high-power blue light (up to ~213 mW/mm²) at 440 nm and 475 nm to measure photoswitching artifacts.
  • In Vivo: Fiber photometry in awake, head-fixed mice (striatum) to validate performance during behavior.
• Mechanistic Investigation: Used AlphaFold3 to predict structural states (open/closed) and guide site-directed mutagenesis of surface-exposed lysine residues to improve signal size.

3. Key Contributions

• ScaRCaMP-1.0: A novel red GECI based on cpmScarlet-I3 that exhibits negligible blue-light photoswitching.
• ScaRCaMP-2.0: An improved variant (K132Y mutation) that increases the calcium response size while maintaining photostability.
• Mechanistic Insight: Identification of surface-exposed lysine residues ("lysine latches") on the mScarlet-I3 fluorophore that regulate calcium-induced conformational changes.
• Validation of mScarlet Lineage: Demonstrated that mScarlet-based fluorophores are superior scaffolds for creating optogenetics-compatible biosensors compared to mApple or mRuby.

4. Key Results

• Performance & Photostability:

  • ScaRCaMP-1.0 showed a moderate calcium response ($\Delta F/F_0 \approx -13\%$) with an inverse response (fluorescence decreases upon calcium binding).
  • Blue-Light Resistance: Under high-power blue light (>200 mW/mm²), ScaRCaMP-1.0 exhibited minimal photoswitching ($\Delta F/F_0 \approx 1\%$). In contrast, jRGECO1a showed ~30-fold larger artifacts, and jRCaMP1a/b showed ~2-fold larger artifacts.
  • Kinetics: The photoswitching artifacts in ScaRCaMP-1.0 were monoexponential and rapid, allowing for easy baseline correction, unlike the complex multi-exponential shifts seen in jRCaMP1b.
  • Comparison: Even the recently reported PinkyCaMP (also based on cpmScarlet) showed significant photoswitching under these conditions, highlighting the importance of preserving the native fluorophore environment in ScaRCaMP-1.0.

• In Vivo Functionality:

  • Successfully detected calcium transients in the striatum of awake mice using fiber photometry.
  • Signals were detectable and correlated with neural activity, though the amplitude was smaller than jRCaMP1b.
  • Demonstrated compatibility with green GECIs (jGCaMP8m) for dual-color imaging.

• Structural Engineering (ScaRCaMP-2.0):

  • AlphaFold3 predicted that a linker isoleucine (Ile79) interacts with surface lysines (Lys96 and Lys132) to "latch" the beta-barrel.
  • Mutating K132 to Tyrosine (K132Y) increased the calcium response to $\Delta F/F_0 \approx -22\%$ without compromising blue-light photostability.
  • This confirmed that the "lysine latch" mechanism is critical for signal generation and can be tuned to improve sensitivity.

• Photophysical Properties:

  • ScaRCaMP-1.0 has low cooperativity (Hill coefficient $n_H \approx 0.87$), resulting in a linear response to calcium concentration, which is useful for monitoring graded calcium changes rather than just spike detection.
  • High apparent affinity ($IC_{50} \approx 42$ nM).

5. Significance

This work addresses a critical bottleneck in systems neuroscience: the ability to simultaneously manipulate (optogenetics) and record (calcium imaging) neural circuits without spectral interference.

• Optogenetic Compatibility: ScaRCaMP-1.0 and 2.0 enable the use of high-power blue light for optogenetic stimulation without the confounding artifacts that plague current red GECIs. This is particularly vital for experiments requiring strong stimulation or deep-tissue imaging where low-power light is insufficient.
• Design Paradigm: The study establishes that maintaining the native, photostable environment of mScarlet fluorophores is key to avoiding photoswitching, offering a new design strategy for future biosensors.
• Future Applications: These tools facilitate multiplexed imaging (green + red) and all-optical physiology experiments in vivo, opening new avenues for dissecting complex neural circuits. The identification of the K132Y mutation provides a clear path for further engineering of mScarlet-based sensors with higher sensitivity.